miR-223 causes the reduction of PDS5B protein levels and promotes the growth of pancreatic cancer cells, whereas increase of PDS5B by overexpressing PDS5B or miRNA-223 inhibitor inhibits cancer cell growth [178]. This evidence concerns the gene PDS5B and pancreatic neoplasm.